Literature DB >> 12942317

Hyperammonaemia as a cause of psychosis in an adolescent.

Amaya Bélanger-Quintana1, Mercedes Martínez-Pardo, María José García, Bendicht Wermuth, Julián Torres, Esperanza Pallarés, Magdalena Ugarte.   

Abstract

UNLABELLED: Diseases that cause hyperammonaemia usually appear during the neonatal period or during the first months of life as severe neurological metabolic distress. In some cases, as the one reported here, the age of onset and initial symptoms are non-specific and the episodes of acute metabolic encephalopathy may be attributed to encephalitis, poisoning or psychiatric problems. Our patient had N-acetyl glutamate synthetase deficiency due to a lack of activation by L-arginine. Treatment with N-carbamylglutamate was successful in maintaining normal ammonia levels.
CONCLUSION: We emphasise the importance of measuring ammonia levels in patients with neurological or psychiatric symptoms as part of their diagnostic work-up.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12942317     DOI: 10.1007/s00431-002-1126-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Late-onset form of partial N-acetylglutamate synthetase deficiency.

Authors:  O N Elpeleg; J P Colombo; N Amir; C Bachmann; H Hurvitz
Journal:  Eur J Pediatr       Date:  1990-06       Impact factor: 3.183

2.  N-acetylglutamate synthetase deficiency: clinical and laboratory observations.

Authors:  A L Pandya; R Koch; F A Hommes; J C Williams
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  N-acetylglutamate synthetase deficiency: favourable experience with carbamylglutamate.

Authors:  A A Morris; S W Richmond; S J Oddie; M Pourfarzam; V Worthington; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

4.  N-acetylglutamate synthetase deficiency, a second patient.

Authors:  C Bachmann; M Brandis; E Weissenbarth-Riedel; R Burghard; J P Colombo
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

5.  N-acetylglutamate synthetase deficiency: a disorder of ammonia detoxication.

Authors:  C Bachmann; S Krähenbühl; J P Colombo; G Schubiger; K H Jaggi; O Tönz
Journal:  N Engl J Med       Date:  1981-02-26       Impact factor: 91.245

6.  A 6-year-old boy with hyperammonaemia: partial N-acetylglutamate synthase deficiency or portosystemic encephalopathy?

Authors:  D Broere; W G van Gemert; C M Kneepkens; D M Neele; R A Manoliu; J A Rauwerda; M S van der Knaap
Journal:  Eur J Pediatr       Date:  2000-12       Impact factor: 3.183

7.  Normal N-acetylglutamate concentration measured in liver from a new patient with N-acetylglutamate synthetase deficiency: physiologic and biochemical implications.

Authors:  J Vockley; C M Vockley; S P Lin; M Tuchman; T C Wu; C Y Lin; M R Seashore
Journal:  Biochem Med Metab Biol       Date:  1992-02

8.  N-acetylglutamate synthetase deficiency: diagnosis, management and follow-up of a rare disorder of ammonia detoxication.

Authors:  G Schubiger; C Bachmann; P Barben; J P Colombo; O Tönz; D Schüpbach
Journal:  Eur J Pediatr       Date:  1991-03       Impact factor: 3.183

Review 9.  Alternative pathway therapy for urea cycle disorders.

Authors:  F Feillet; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

10.  Partial N-acetylglutamate synthetase deficiency in a 13-year-old girl: diagnosis and response to treatment with N-carbamylglutamate.

Authors:  B Plecko; W Erwa; B Wermuth
Journal:  Eur J Pediatr       Date:  1998-12       Impact factor: 3.183

View more
  12 in total

1.  N-carbamylglutamate enhancement of ureagenesis leads to discovery of a novel deleterious mutation in a newly defined enhancer of the NAGS gene and to effective therapy.

Authors:  Sandra K Heibel; Nicholas Ah Mew; Ljubica Caldovic; Yevgeny Daikhin; Marc Yudkoff; Mendel Tuchman
Journal:  Hum Mutat       Date:  2011-09-09       Impact factor: 4.878

Review 2.  A review of basic to clinical studies of the association between hyperammonemia, methamphetamine.

Authors:  Marzieh Jafari Fakharbad; Mohammad Moshiri; Mohammad Mehdi Ommati; Mehdi Talebi; Leila Etemad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-05-23       Impact factor: 3.195

Review 3.  Recommendations for the Diagnosis and Therapeutic Management of Hyperammonaemia in Paediatric and Adult Patients.

Authors:  Amaya Bélanger-Quintana; Francisco Arrieta Blanco; Delia Barrio-Carreras; Ana Bergua Martínez; Elvira Cañedo Villarroya; María Teresa García-Silva; Rosa Lama More; Elena Martín-Hernández; Ana Moráis López; Montserrat Morales-Conejo; Consuelo Pedrón-Giner; Pilar Quijada-Fraile; Sinziana Stanescu; Mercedes Martínez-Pardo Casanova
Journal:  Nutrients       Date:  2022-07-02       Impact factor: 6.706

Review 4.  Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults.

Authors:  A Cartagena; A N Prasad; C A Rupar; M Strong; M Tuchman; N Ah Mew; C Prasad
Journal:  Can J Neurol Sci       Date:  2013-01       Impact factor: 2.104

Review 5.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

Review 6.  Neurological implications of urea cycle disorders.

Authors:  A L Gropman; M Summar; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2007-11-23       Impact factor: 4.982

Review 7.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

8.  Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency.

Authors:  Johannes Häberle
Journal:  Ther Clin Risk Manag       Date:  2011-08-02       Impact factor: 2.423

9.  Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases.

Authors:  Elena Martín-Hernández; Luis Aldámiz-Echevarría; Esperanza Castejón-Ponce; Consuelo Pedrón-Giner; María Luz Couce; Juliana Serrano-Nieto; Guillem Pintos-Morell; Amaya Bélanger-Quintana; Mercedes Martínez-Pardo; María Teresa García-Silva; Pilar Quijada-Fraile; Isidro Vitoria-Miñana; Jaime Dalmau; Rosa A Lama-More; María Amor Bueno-Delgado; Mirella Del Toro-Riera; Inmaculada García-Jiménez; Concepción Sierra-Córcoles; Mónica Ruiz-Pons; Luis J Peña-Quintana; Inmaculada Vives-Piñera; Ana Moráis; Elena Balmaseda-Serrano; Silvia Meavilla; Pablo Sanjurjo-Crespo; Celia Pérez-Cerdá
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

10.  N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment.

Authors:  Nicholas Ah Mew; Ljubica Caldovic
Journal:  Appl Clin Genet       Date:  2011-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.